Humana (HUM) Receivables (2009 - 2026)

Humana (HUM) has reported Receivables for 18 consecutive years, with $5.7 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables rose 26.44% year-over-year to $5.7 billion in Q2 2026; TTM through Jun 2026 was $5.7 billion, a 26.44% increase from a year earlier, with the FY2025 full-year figure at $3.3 billion, up 20.93% from the prior year.
• Receivables was $5.7 billion for Q2 2026 at Humana, up from $5.2 billion in the prior quarter.
• Over five years, Receivables peaked at $5.7 billion in Q2 2026 and troughed at $357.0 million in Q4 2023.
• A 5-year average of $3.0 billion and a median of $3.1 billion in 2022 frame the typical range for Receivables.
• Across the five-year window, Receivables tumbled 82.98% in 2023 and surged 808.33% in 2025, its largest moves.
• Over 5 years, Receivables stood at $2.1 billion in 2022, then plunged by 82.98% to $357.0 million in 2023, then grew by 0.84% to $360.0 million in 2024, then surged by 808.33% to $3.3 billion in 2025, then surged by 74.16% to $5.7 billion in 2026.
• The last three Receivables figures came in at $5.7 billion (Q2 2026), $5.2 billion (Q1 2026), and $3.3 billion (Q4 2025), per Business Quant data.